Alloferons—immunomodulatory peptides

Details Alloferons—immunomodulatory peptides Alloferons—immunomodulatory peptides

2003-12-23

2008-12-09

Mosher, Mary E (Department: 1648)

Drug, bio-affecting and body treating compositions

Nonspecific immunoeffector, per se ; or nonspecific...

C514S012200, C514S013800, C514S014800, C514S015800

Reexamination Certificate

active

07462360

ABSTRACT:
The invention belongs to the field of biologically active peptides specifically stimulating antiviral, antimicrobial and antitumor activity of the human and animal immune system.

REFERENCES:
patent: 5480782 (1996-01-01), Nonoyama et al.
patent: 5482711 (1996-01-01), Medenica
patent: 5714577 (1998-02-01), Montelaro et al.
patent: 5804558 (1998-09-01), Lehrer et al.
patent: 5827516 (1998-10-01), Urban et al.
patent: 4334600 (1995-04-01), None
patent: 0299828 (1989-01-01), None
patent: 0320528 (1989-06-01), None
patent: 0856519 (1998-08-01), None
patent: WO 81/03124 (1981-11-01), None
patent: WO 90/14098 (1990-11-01), None
patent: WO 96/04005 (1996-02-01), None
patent: WO 96/22067 (1996-07-01), None
Guo et al (PNAS 101:9205-9210, 2004).
Bowie et al (Science 247:1306-1310, 1990).
Trinchieri, G., “Biology of Natural Killer Cells”, Advances in Immunology, 1989, pp. 187-376, vol. 47, Academic Press, Inc.
Brittenden, J. et al., “Natural Killer Cells and Cancer”, Cancer: Interdisciplinary International Journal of the American Cancer Society; Apr. 1, 1996, pp. 1226-1243, vol. 77, No. 7, John Witey & Sons, Inc.
Bekkering, F. et al., “Ultrarapid Hepatitis C Virus Clearance by Daily High-Dose Interferon in Non-Responders to Standard Therapy” Journal of Hepatology, 1998; pp. 960-964; vol. 28; European Association for the Study of Liver; Denmark, 1998.
Cardamakis, E. et al, Treatment of Recurrent Genital Herpes with Interferon Alpha-2α Gynecol. Obstet Invest., 1998, pp. 54-57, vol. 46, No. S. Karger AG, 1998.
Zee, B. et al, “Quality-Adjusted Time Without Symptoms or Toxicicty Analysis of Interferon Maintenance in Multiple Myeloma”, Journal of Clinical Oncology, Aug. 1998, pp. 2834-2839, vol. 16, No. 8, W.B. Saunders Company.
Aviles, A. et al., Maintenance Therapy with Interferon Alfa 2b in Hodgkin Disease, Leukemia and Lymphoma, 1998, pp. 651-656, vol. 30, No. 5/6, Hardwood Academic Publishers.
Gilbert, H., “Long Term Treatment of Myeloproliferative Disease with Interferno-α-2b”, Cancer; Interdisiplinary International Journal of the American Cancer Society, Sep. 15, 1998, pp. 1205-1213, vol. 83, No. 6; John Wiley & Sons, Inc.
Durelli, L. et al; “Interferon alpha treatment of relapsing-remitting multiple sclerosis: long-term study of the correlations between clinical and magnetic resonance imaging results and effects on the immune function”, Multiple Sclerosis: Clinical and Laboratory Research, Sep. 1994, pp. 32-37, vol. 1, Supplement 1, Stockton Press, Brussels, Belgium.
Schneider, L. et al., “Long-Term Therapy with Recombinant Interferon-gamma (rIFN-y) for Atopic Dermatitis”, Annals of Allergy, Asthma & Immunology, Mar. 1998, pp. 263-268, vol. 80, No. 3.
Kullberg, B.J., “Trens in Immunotherapy of Fungal Infections”, Eur. J. Clin. Microbiol. Infect. Dis, Jan. 1997, pp. 51-55, vol. 16.
Akaza, H. et al., “Bropirimnie, an orally active Anticancer Agent for Superficial Bladder Cancer”, Eur. Urol., Jul. 1998, pp. 107-110, vol. 34, Karger AG, Base!
Naumann; U. et al; “Complete cDNA and Gene Sequence of the Developmentally Regulated Arylphorin of Calliphora Vicina and its Homology to Insect Hemolymph Proteins and Arthropod Hemocyanins”, Biochemical and Biophysical Research Communications, Jun. 28, 1991, pp. 963-972, vol. 177, No. 3, Academic Press, Inc.
Russian Ministry of Health Certification No. 002829/01 issued Sep. 22, 2003, for Allokin-alfa.
Russian Ministry of Health Certification No. 002830/02 issued Sep. 22, 2003, for Alloferon.
English language Abstract of Russian article: Ershov, F.I., et al., “Allokine-alpha effect on the course of chronic genital herpes relapses”;Materia Medica, 2003, No. 4 (40), pp. 103-111.
Russian language article Ershov, F.I., et al., “Allokine-alpha effect on the course of chronic genital herpes relapses”;Materia Medica, 2003, No. 4 (40), pp. 103-111.
Chernysh, Sergey, et al., “Antiviral and Antitumor Peptides From Insects”, PNAS, Oct. 1, 2002, vol. 99, No. 20., pp. 12628-12632.

Affiliated with

Also associated with

Rating

Alloferons—immunomodulatory peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alloferons—immunomodulatory peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alloferons—immunomodulatory peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4037450